AmebaGone

AmebaGone

Private
Madison, WisconsinHealthcare & Life Scienceshttps://amebagone.com/

Last Round

Grant

May 1, 2017

Total Funding Raised

$1.48M

Company Overview

AmebaGone is a biotechnology company that develops amoebae technologies designed to destroy intractable bacterial infections in crops, humans, and the environment.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Hardware Sales

AI Layer

Non-AI

Keywords

anti-biofilm agentsbacterial biofilmantibiotic resistancebiofilm therapeuticscontract research organizationCROantimicrobial resistanceAMRadjuvant therapyresistance breakerbiofilm research servicessuperbugdrug discoverymedical device testingBacterial Keratitiscrop protection

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AmebaGone Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

AmebaGone Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantMay 1, 2017
GrantFeb 29, 2016
GrantNov 2, 2015
GrantJun 1, 2015
GrantSep 25, 2014

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 1, 2017

    Secured $998K from National Eye Institute and NIH RADx.

  • Feb 29, 2016

    $75K grant received from two organizations.

AmebaGone Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AmebaGone Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AmebaGone's valuation, stock price, and market status.

Firmographic Details

HeadquartersMadison, Wisconsin
Employee Range6
Year Founded2010
Last FundingMay 1, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.